Publications

Dal Bello S, Lorenzut S, Saccomano E, Tereshko Y, Gigli GL, Pucillo CE, Valente M. NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy. Pharmaceuticals (Basel). 2024 Jan 23;17(2):150. doi: 10.3390/ph17020150.

Zelante T, Paolicelli G, Fallarino F, Gargaro M, Vascelli G, De Zuani M, Fric J, Laznickova P, Kohoutkova MH, Macchiarulo A, Dolciami D, Pieraccini G, Gaetani L, Scalisi G, Trevisan C, Frossi B, Pucillo C, De Luca A, Nunzi E, Spaccapelo R, Pariano M, Borghi M, Boscaro F, Romoli R, Mancini A, Gentili L, Renga G, Costantini C, Puccetti M, Giovagnoli S, Ricci M, Antonini M, Calabresi P, Puccetti P, Di Filippo M, Romani L. A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis. Sci Rep. 2024 Mar 20;14(1):6651. doi: 10.1038/s41598-024-57400-8.

Sulsenti R, Scialpi GB, Frossi B, Botti L, Ferri R, Tripodi I, Piva A, Sangaletti S, Pernici D, Cancila V, Romeo F, Chiodoni C, Lecis D, Bianchi F, Fischetti I, Enriquez C, Crivelli F, Bregni M, Renne G, Pece S, Tripodo C, Pucillo CE, Colombo MP, Jachetti E. Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer. Cancer Immunol Res. 2024 Sep 3;12(9):1147-1169. doi: 10.1158/2326-6066.CIR-23-0792.

Locatello LG, Lobo D, Saibene AM, Pucillo C. Editorial: The current role of allergy in otolaryngological disorders. Front Allergy. 2024 Oct 10;5:1498340. doi: 10.3389/falgy.2024.1498340. eCollection 2024.

Locatello LG, Tonon S, Mele V, Santini S, Miani C, Pucillo CEM. Update on the Biological and Clinical Relevance of Mast Cells in Chronic Rhinosinusitis with Nasal Polyps. Biomedicines. 2024 Nov 20;12(11):2647. doi: 10.3390/biomedicines12112647.

Blank U, Pucillo C. Editorial: Advances in mast cell physiology and mast cell-driven diseases. Front Immunol. 2023 Oct 19;14:1303726. doi: 10.3389/fimmu.2023.1303726. eCollection 2023.

 De Zuani M, Dal Secco C, Tonon S, Arzese A, Pucillo CEM, Frossi B. LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells. Front Immunol. 2022 Feb 17;13:835348. doi: 10.3389/fimmu.2022.835348. eCollection 2022

Levi-Schaffer F, Gibbs BF, Hallgren J, Pucillo C, Redegeld F, Siebenhaar F, Vitte J, Mezouar S, Michel M, Puzzovio PG, Maurer M.  Selected recent advances in understanding the role of human mast cells in health and disease. J Allergy Clin Immunol. 2022 Jun;149(6):1833-1844. doi: 10.1016/j.jaci.2022.01.030. Epub 2022 Mar 8.

 Beltrami AP, De Martino M, Dalla E, Malfatti MC, Caponnetto F, Codrich M, Stefanizzi D, Fabris M, Sozio E, D'Aurizio F, Pucillo CEM, Sechi LA, Tascini C, Curcio F, Foresti GL, Piciarelli C, De Nardin A, Tell G, Isola M. Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery. Int J Mol Sci. 2022 Aug 15;23(16):9161. doi: 10.3390/ijms23169161.

Da Porto A, Tascini C, Colussi G, Peghin M, Graziano E, De Carlo C, Bulfone L, Antonello M, Sozio E, Fabris M, Curcio F, Pucillo C, Catena C, Sechi LA. Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection. Front Med (Lausanne). 2022 Aug 19;9:988686. doi: 10.3389/fmed.2022.988686. eCollection 2022.

 Codrich M, Dalla E, Mio C, Antoniali G, Malfatti MC, Marzinotto S, Pierobon M, Baldelli E, Di Loreto C, Damante G, Terrosu G, Pucillo CEM, Tell G. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN. J Exp Clin Cancer Res. 2021 Jun 21;40(1):198

Sulsenti R, Frossi B, Bongiovanni L, Cancila V, Ostano P, Fischetti I, Enriquez C, Guana F, Chiorino G, Tripodo C, Pucillo CE, Colombo MP, Jachetti E. Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma. Front Immunol. 2021 Mar 2;12:622001. doi: 10.3389/fimmu.2021.622001. (IF: 5,085)

Tonon S, Martinis E, Pucillo CEM, Mion F. il-10 Gene Locus DNA Methylation in Regulatory B Cells. Methods Mol Biol. 2021;2270:323-339. (IF: 10,71)

Mion F, Martinis E, Pucillo CEM, Tonon S. Purification of Murine and Human IL-10-Producing B Cells from Different Anatomical Compartments. Methods Mol Biol. 2021;2270:61-76. (IF: 10,71)

Valeri V, Tonon S, Vibhushan S, Gulino A, Belmonte B, Adori M, Karlsson Hedestam GB, Gautier G, Tripodo C, Blank U, Mion F, Pucillo CEM. Mast cells crosstalk with B cells in the gut and sustain IgA response in the inflamed intestine. Eur J Immunol. 2021 Feb;51(2):445-458. (IF: 4,179)

Pucillo, C., Vitale, G. Crossroads between immune responses and physiological regulation: Metabolic control of resistance versus tolerance against disease Eur J Immunol. 2020 Apr;50(4):484-489 (IF: 4,179) 

De Biasi, S., Lo Tartaro, D., Meschiari, M., et al. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 Sep;50(9):1283-1294. (IF: 4,179)

Cossarizza A, et al. J. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol. 2019 Oct;49(10):1457-1973.

 Codrich M, Comelli M, Malfatti MC, Mio C, Ayyildiz D, Zhang C, Kelley MR, Terrosu G, Pucillo CEM, Tell G. Inhibition of APE1-endonuclease activity affects DNA Repair (Amst). 2019 Oct;82:102675. doi: 10.1016/j.dnarep.2019.10267

Tonon S, Mion F, Dong J, Chang H-D, Dalla E, Scapini P, Perruolo,G Zanello A, Dugo M, Cassatella MA,  Colombo MP, Radbruch A and Pucillo CE. Cells competent for IL-10 production are characterized by a specific methylation signature” Eur J Immunol. 2019 Apr 29. doi: 10.1002/eji.201848025

Jachetti E, D'Incà F, Danelli L, Magris R, Dal Secco C, Vit F, Cancila V, Tripodo C, Scapini P, Colombo MP, Pucillo C, Frossi B. Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity. J Leukoc Biol. 2019 Apr;105(4):633-644. (IF: 4.289)

Frossi B, Antoniali G, Yu K, Akhtar N, Kaplan MH, Kelley MR, Tell G, Pucillo CEM. Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination. J Biol Chem. 2019 Mar 29;294(13):5198-5207. (IF: 4.010)

De Zuani M, Paolicelli G, Zelante T, Renga G, Romani L, Arzese A, Pucillo CEM, Frossi B. Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus. Front Immunol. 2018 Nov 30; 9:2829. (IF: 5.511)

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L. IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut. Cell Rep. 2018 May 8;23(6):1767-1778.  (IF: 8.282)

Jachetti E, Cancila V, Rigoni A, Bongiovanni L, Cappetti B, Belmonte B, Enriquez C, Casalini P, Ostano P, Frossi B, Sangaletti S, Chiodoni C, Chiorino G, Pucillo CE, Tripodo C, Colombo MP. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer. Cancer Immunol Res. 2018 Mar 9. pii: canimm.0385.2017. (IF: 8.284)

Maurer M, Pucillo C. What we know (and don't know) about the biology and functions of mast cells and basophils. Immunol Rev. 2018 Mar;282(1):5-7. (IF: 9.614)

Frossi B, Mion F, Sibilano R, Danelli R, and Pucillo C Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity? Immunological Reviews. 2018;1–12 (IF: 9.614)

Cossarizza A, Chang HD, et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol. 2017 Oct;47(10):1584-1797 (IF: 4,179)

Mion F, Vetrano S, Tonon S, Valeri V, Piontini A, Burocchi A, Petti L, Frossi B, Gulino A, Tripodo C, Colombo MP and Pucillo CE Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer. 2017 Oncoimmunology (IF:7,6)

Frossi B, Mion F, Tripodo C, Colombo MP and Pucillo CE Rheostatic functions of mast cells in the control of innate and adaptive immune responses Trends In Imm. 2017 in press (IF:11,6)

Moretti S, Renga G, Oikonomou V, Galosi1 C, Pariano M,. Iannitti RG, Borghi M , De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld J-C, Bereshchenko O , Sportoletti P , Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V and Romani L. .A Mast Cells/ILC2/Th9 pathway promotes lung inflammation in Cystic Fibrosis, Nat Commun. 2017 Jan 16;8:14017. (IF:11,329)

Frossi B, Tripodo C, Guarnotta C, Carroccio A, De Carli M, De Carli S, Marino M, Calabrò A, Pucillo C. Mast cells are associated with the onset and progression of celiac disease. J Allergy Clin Immunol. 2017 Apr;139(4):1266-1274 (IF: 12,485)

Frossi B, Mion F, Pucillo C. Deciphering new mechanisms on T-cell costimulation by human mast cells. Eur J Immunol. 2016 May;46(5):1105-8. doi: 10.1002/eji.201646390. (IF: 4,179)

Frossi B, De Carli S, Bossi F, Pucillo C, De Carli M. Co-Occurrence of Chronic Spontaneous Urticaria with Immunoglobulin A Deficiency and Autoimmune Diseases. Int Arch Allergy Immunol. 2016;169(2):130-4. (IF: 2,389)

Betto E, Usuelli V, Mandelli A, Badami E, Sorini C, Capolla S, Danelli L, Frossi B, Guarnotta C, Ingrao S, Tripodo C, Pucillo C, Gri G, Falcone M. Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10(+) phenotype. Clin Immunol. 2015 Dec 27. pii: S1521-6616(15)30082-6. (IF: 4,034)

Danelli L, Frossi B, Pucillo CE. Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology. 2015 Mar 24;4(4) (IF: 7,644)

Mekori YA, Hershko AY, Frossi B, Mion F, Pucillo CE. Integrating innate and adaptive immune cells: Mast cells as crossroads between regulatory and effector B and T cells. Eur J Pharmacol. 2015 May 5;778:84-9. (IF: 2,730) 

D'Incà F, Pucillo CE. Exosomes: tiny clues for mast cell communication. Front Immunol. 2015 Feb 18;6:73. doi: 10.3389/fimmu.2015.00073. eCollection 2015. (IF: 5,695)

Danelli L, Frossi B, Gri G, Mion F, Guarnotta C, Bongiovanni L, Tripodo C, Mariuzzi L, Marzinotto S, Rigoni A, Blank U, Colombo MP, Pucillo CE. Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment. Cancer Immunol Res. 2015 Jan;3(1):85-95. (IF: 8.284)

Rigoni A, Colombo MP, Pucillo C. The Role of Mast Cells in Molding the Tumor Microenvironment. Cancer Microenviron. 2015 Dec;8(3):167-76.

Mion F, D'Incà F, Danelli L, Toffoletto B, Guarnotta C, Frossi B, Burocchi A, Rigoni A, Gerdes N, Lutgens E, Tripodo C, Colombo MP, Rivera J, Vitale G, Pucillo CE. Mast cells control the expansion and differentiation of IL-10-competent B cells. J Immunol. 2014 Nov 1;193(9):4568-79. (IF: 4,985)

Mion F., Tonon S; Toffoletto B; Cesselli D, Pucillo C*,  Vitale G*. : IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation Mol Imm 2014 62(2):266-76. (IF:3,375)

Sibilano R., Frossi B., Pucillo CE A complex interplay of positive and negative signaling pathways in mast cell activation. Eur J. Immunol 2014 44(9):2558-66 (IF: 4,179)

Sibilano R, Pucillo C, Frossi B. Modulation of FcεRI-dependent mast cell response by OX40L. Methods Mol Biol. 2014;1155:23-30.

Sibilano R, Pucillo CE, Gri G. Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation. Mol Immunol. 2014 Mar 18. pii:S0161-5890(14)00049-2. (IF: 3,375)

 Franco G, Guarnotta C, Frossi B, Piccaluga PP, Boveri E, Gulino A, Fuligni F, Rigoni A, Porcasi R, Buffa S, Betto E, Florena AM, Franco V, Iannitto E, Arcaini L, Pileri SA, Pucillo C, Colombo MP, Sangaletti S, Tripodo C. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. Blood. 2014 Mar 20;123(12):1836-49 (IF: 11,841)

Pignatti P, Frossi B, Pala G, Negri S, Oman H, Perfetti L, Pucillo C, Imbriani M, Moscato G. Oxidative activity of ammonium persulfate salt on mast cells and basophils: implication in hairdressers' asthma. Int Arch Allergy Immunol.2013;160(4):409-19 (IF: 2,389)

Giunta M, Pucillo C. BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy. Rev Bras Hematol Hemoter. 2012;34(5):323-4. doi: 10.5581/1516-8484.20120082.

Vitale G, Pucillo CE. New roots for IgE-producing B cells. Cell Mol Immunol. 2012 Jun 11. doi: 10.1038/cmi.2012.14. [Epub ahead of print] PubMed PMID: 22684126. (IF: 5,193)

Gri G, Frossi B, D'Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C. Mast cell: an emerging partner in immune interaction. Front Immunol. 2012;3:120. (IF: 5,695)

Sibilano R, Frossi B, Calvaruso M, Danelli L, Betto E, Dall'agnese A, Tripodo C, Colombo MP, Pucillo CE, Gri G. The aryl hydrocarbon receptor modulates acute and late mast cell responses. J Immunol. 2012 Jul 1;189(1):120-7. (IF: 4,985)

Sibilano R, Frossi B, Suzuki R, D'Incà F, Gri G, Piconese S, Colombo MP, Rivera J, Pucillo CE. Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. J Allergy Clin Immunol. 2012 Sep;130(3):751-760. (IF: 12,485)

Bossi F, Frossi B, Radillo O, Cugno M, Tedeschi A, Riboldi P, Asero R, Tedesco F, Pucillo C. Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy. 2011 Dec;66(12):1538-45. (IF: 6,335)

Sibilano R, Gri G, Frossi B, Tripodo C, Suzuki R, Rivera J, MacDonald AS, Pucillo CE. Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation. J Leukoc Biol. 2011 Oct;90(4):831-8. (IF: 4,165)

Frossi B, D'Incà F, Crivellato E, Sibilano R, Gri G, Mongillo M, Danelli L, Maggi L, Pucillo CE. Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions. Eur J Immunol. 2011 Jul;41(7):1872-82. (IF: 4,179)

Mimmi MC, Picotti P, Corazza A, Betto E, Pucillo CE, Cesaratto L, Cedolini C, Londero V, Zuiani C, Bazzocchi M, Esposito G. High-performance metabolic marker assessment in breast cancer tissue by mass spectrometry. Clin Chem Lab Med. 2011 Feb;49(2):317-24 (IF: 3,017)

Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmentalorigin and population diversity. Mol Immunol. 2010 Nov-Dec;48(1-3):1-8. (IF: 3,375)

Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA. Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma. Am J Pathol. 2010 Aug;177(2):792-802  (IF: 4,206)

Frossi B, Gri G, Tripodo C, Pucillo C. Exploring a regulatory role for mast cells: ‘MCregs’? Trends Immunol. 2010 Mar;31(3):97-102. (IF:11,433)

Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation towards IgA-secreting plasma cells. Blood. 2010 Apr 8;115(14):2810-7 (IF: 11,841)

Tripodo C, Iannitto E, Florena A.M., Pucillo C, Piccaluga PP, Franco V and Pileri SA. Gamma-delta T-cell Lymphomas Nat Rev Clin Oncol. 2009 Dec;6(12):707-17. (IF:18,786)

Piconese S., Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, Pedotti R, Pucillo C* and Colombo M Mast cells counteract regulatory T cell suppression through interleukin-6 and OX40/OX40L axis toward Th17 cell differentiation. Blood. 2009 Sep 24;114(13):2639-48. (IF: 11,841) *Corresponding author

Bossi F, Rizzi L, Bulla R, Debeus A, Tripodo C, Picotti P, Betto E, Macor P, Pucillo C, Würzner R, Tedesco F. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood. 2009 Apr 9;113(15):3640-8. (IF: 11,841)

Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity. 2008 Nov;29(5):771-81. (IF: 24,841)

Merluzzi S, Gri G, Gattei V, Pagano M, Pucillo C. APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferation. Mol Immunol. 2008 Aug;45(14):3731-9. (IF:3,375)

Arcidiacono D, Odom S, Frossi B, Rivera J, Paccani SR, Baldari CT, Pucillo C,Montecucco C, de Bernard M. The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production. Cell Microbiol. 2008 Apr;10(4):899-907. (IF:4,460)

D'Orlando O, Gri G, Cattaruzzi G, Merluzzi S, Betto E, Gattei V, Pucillo C.Outside inside signalling in CD40-mediated B cell activation. J Biol Regul Homeost Agents. 2007;21(3-4):49-62. (IF:2,046)

Gennaro Esposito, Stefano Ricagno, Alessandra Corazza, Enrico Rennella, Devrim Gümral, Maria Chiara Mimmi, Elena Betto, Carlo E.M. Pucillo, Federico Fogolari, Paolo Viglino, Sara Raimondi, Sofia Giorgetti, Benedetta Bolognesi, Giampaolo Merlini, Monica Stoppini, Martino Bolognesi and Vittorio Bellotti. The controlling roles of Trp60 and Trp95 in β2-microglobulin function, folding and amyloid aggregation properties J Mol Biol 2008. 9; 378(4):887-897. (IF:4,517)

Frossi B., de Carli M., Piemonte M., Pucillo C. (2008) Oxidative stress exerts an opposite regulatory effect on cytokine production by Th1 and Th2 human T cells, 2008. Mol. Immunol 45(1):58-64. (IF:3,375)

Merluzzi S., D'Orlando O., Leonardi A., Vitale G. and Carlo Pucillo TRAF2 and p38 are involved in B cells CD40-mediated APE/Ref-1 nuclear translocation: a novel pathway in B cell activation 2008. Mol. Immunl; 45(1):76-86. (IF:3,375)

Cattaruzzi G., Altamura S., Tessari M., Fustighi A., Giancotti V., Pucillo C. and Manfioletti G. 2007 The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization. Nucleic Acids Res. 35(6):1751-60. (IF:9,202)

Frossi B., Hirsh E., Rivera J. and Pucillo C. 2007 Selective Activation of Fyn/PI3K and p38 MAPK Regulates IL-4 Production in BMMC under Nontoxic Stress Condition. J. Immunol; 178 (4): 2549-55. (IF: 4,985)

Alverdi V, Di Pancrazio F, Lippe G, Pucillo C, Casetta B, Esposito G. 2005. Determination of protein phosphorylation sites by mass spectrometry: a novel electrospray-based method. Rapid Commun Mass Spectrom.; 19(22):3343-8. (IF: 2,226)

Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Steffan A, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V. 2005. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. J Immunol Methods. ;305(1):20-32. (IF: 1,858)

Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Del Principe MI, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V. 2005. Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol. ;204(1):113-23. (IF: 4,155)

Degan M, Rupolo M, Bo MD, Stefanon A, Bomben R, Zucchetto A, Canton E, Berretta M, Nanni P, Steffan A, Ballerini PF, Damiani D, Pucillo C, Attadia V, Colombatti A, Gattei V. 2004. Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. Clin Lymphoma. 5(2):123-6. (continued as Clinical Lymphoma Myeloma and Leukemia) (IF: 2,559)

Degan M, Bomben R, Bo MD, Zucchetto A, Nanni P, Rupolo M, Steffan A, Attadia V, Ballerini PF, Damiani D, Pucillo C, Poeta GD, Colombatti A, Gattei V. 2004. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol.; 126(1):29-42. (IF: 5,812)

Altomonte M, Visintin A, Tecce R, Leonardi A, Calabro L, Fonsatti E, Pucillo C, Maio M. 2004.Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma. J Cell Physiol.; 200(2):272-6. (IF: 4,155)

Frossi B., De Carli M. and. Pucillo C. 2004. Mast cell an antenna of the microenvironment that directs the immune response J. Leuk Biol. 75(4):579-85. (IF: 4,165)

Benedetti F.., Berti F., Brady K., Colombatti A., Pauletto A., Pucillo C. and Thomas N. R. 2004. A Novel Catalytic Motif revealed by the model structure of Amide Hydrolyzing Antibody 312D6. Chem.Biochem. 5(1): 129-131. (IF: 3,088)

Merluzzi S., Moretti M., Zwollo P., Sigvardsson M., Vitale G. and Pucillo C. 2004. CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1 dependent redox mechanism J Biol Chem. 279(3): 1777-86. (IF: 4,258)

Frossi B., De Carli M., Daniel KC, Rivera J. and Pucillo C. 2003. Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway Eur. J. Immunol 33(8):2168-77. (IF: 4,179)

Dapas B., Perissin L., Pucillo C., Quadrifoglio F. And Scaggiante B. 2002. Increase in Therapeutic Index of Doxorubicin and Vinblastine by Aptameric Oligonucleotide in Human T Lymphoblastic Drug-Sensitive and Multidrug-Resistant Cells. Antis. Nucleic A. Drug Develop. 12:247–255. (IF:9,202)

Frossi B., Tell G., Spessotto P., Colombatti A., Vitale G. and Pucillo C. 2002. H2O2 induces translocation of APE/Ref-1 to mitochondria in the Raji B-cell line. J. Cell Physiol. 193: 180-186. (IF: 4,155)

Tell G., Crivellato E., Pines A., Paron I., Pucillo C., Manzini G., Bandiera A., Kelley M. R., Di Loreto C., Damante G. 2001. Mitochondrial localization of APE/Ref-1 in thyroid cells Mut res. 485:143-152. (IF: 2,093)

Merluzzi S., Figini M., Colombatti, A. Canevari S. and Pucillo C. Humanized antibodies as potential drugs for therapeutic use Adv Clin Pathol Adv Clin Path. 2000. 2:83-95

Tell, G., Pellizzari, L., Pucillo, C., Puglisi, F., Cesselli, D., Kelley, M.R., Di Loreto, C., and Damante, G. 2000. TSH controls Ref-1 nuclear translocation in thyroid cells. J. Mol. Endocrinol. 24, 383-390. (IF: 2,947)

Tell, G., A. Zecca, D. Cimarosti, L. Pellizzari, P. Spessotto, A. Colombatti, M.R. Kelley, G. Damante, and C. Pucillo. 2000. An "environment to nucleus" signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res.;28(5):1099-1105. (IF:9,202)

Bearz A., Tell G., Colombatti A. , Formisano S., and Pucillo C. 1999. Fibronectin binding promotes association of p125FAK and Zap70 in human T cells. Immunology; 98(4):564-8.

Tell G., Acquaviva R., Formisano S., Fogolari F., Pucillo C. and Damante. 1999. G. Comparative stability analysis of the Thyroid Transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix. Int J Biochem Cell Biol. ;31(11):1339-53. (IF:1,076)

Altomonte, M., C. Pucillo, and M. Maio. 1999. The overlooked "nonclassical" functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells. J Cell Physiol. 179:251-6. (IF: 4,155)

Tell, G., L. Pellizzari, G. Esposito, C. Pucillo, P.E. Macchia, R. Di Lauro, and G. Damante. 1999. Structural defects of a Pax8 mutant that give rise to congenital hypothyroidism. Biochem J. 341:89-93. (IF: 3,562)

Russo, D., G. Tell, L. Marin, M. Tiribelli, M.A. Santucci, and C. Pucillo. 1999. All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-a in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines. Haematologica. 84:955-957. (IF: 6,671)

Bearz, A., G. Tell, A. Colombatti, S. Formisano, and C. Pucillo. 1998. Fibronectin binding promotes a PKC-dependent modulation of NF-kappa B in human T cells. Biochem Biophys Res Commun. 243:732-7. (IF: 2,371)

Tell, G., L. Perrone, D. Fabbro, L. Pellizzari, C. Pucillo, M. De Felice, R. Acquaviva, S. Formisano, and G. Damante. 1998. Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains. Biochem J. 329:395-403. (IF: 3,562)

Tell, G., A. Scaloni, L. Pellizzari, S. Formisano, C. Pucillo, and G. Damante. 1998. Redox potential controls the structure and DNA binding activity of the paired domain. J Biol Chem. 273:25062-72. (IF: 4,258)

Tell, G., L. Pellizzari, D. Cimarosti, C. Pucillo, and G. Damante. 1998. Ref-1 controls pax-8 DNA-binding activity. Biochem Biophys Res Commun. 252:178-83. (IF: 2,371)

Coral, S., C. Pucillo, A. Leonardi, E. Fonsatti, M. Altomonte, and M. Maio. 1997. Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation. Cell Growth Differ. (Continued By: Molecular cancer research) 8:581-8. (IF: 4,510)

Pellizzari, L., G. Tell, D. Fabbro, C. Pucillo, and G. Damante. 1997. Functional interference between contacting amino acids of homeodomains. FEBS Lett. 407:320-4. (IF: 3,519)

Leonardi, A., M. Altomonte, M. Maio, G. Tell, A. Bearz, S. Formisano, and C. Pucillo. 1997. Biphasic control of NF-kappa B activation induced by the triggering of HLA-DR antigens expressed on B cells. Cytokine. 9:295-9. (IF: 2,940)

Fabbro, D., G. Tell, A. Leonardi, L. Pellizzari, C. Pucillo, R. Lonigro, S. Formisano, and G. Damante.1996. In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence. Nucleic Acids Res. 24:3283-8. (IF: 9,202)

Altomonte, M., R. Montagner, C. Pucillo, and M. Maio. 1996. Triggering of target of an antiproliferative antibody-1 (TAPA-1/CD81) up-regulates the release of tumour necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY. Scand J Immunol. 43:367-73. (IF: 2,270)

Fabbro, D., G. Tell, L. Pellizzari, A. Leonardi, C. Pucillo, R. Lonigro, and G. Damante. 1995. Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences. Biochem Biophys Res Commun. 213:781-8. (IF: 2,371)

Bearz, A., G. Tolazzi, A. Leonardi, C. Pucillo, G. Tell, A. Colombatti, and S. Formisano. 1995. Expression, purification and functional characterisation of a Kunitz- type module from chicken type VI collagen. Biochem Biophys Res Commun. 215:1050-5. (IF: 2,371)

Pucillo, C.E., L.D. Palmer, and R.J. Hodes. 1995. Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice. Immunol Res. 14:58-68. (IF: 2,934)

Hathcock, K.S., C.E. Pucillo, G. Laszlo, L. Lai, and R.J. Hodes. 1995. Analysis of thymic subpopulations expressing the activation antigen GL7. Expression, genetics, and function. J Immunol. 155:4575-81. (IF: 4,985)

Hathcock, K.S., G. Laszlo, C. Pucillo, P. Linsley, and R.J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med. 180:631-40. (IF: 11,240)

Segat, D., C. Pucillo, G. Marotta, R. Perris, and A. Colombatti. 1994. Differential attachment of human neoplastic B cells to purified extracellular matrix molecules. Blood. 83:1586-94. (IF: 11,841)

Pucillo, C.E., A. Colombatti, M. Vitale, S. Salzano, G. Rossi, and S. Formisano. 1993. Interactions of promonocytic U937 cells with proteins of the extracellular matrix. Immunology. 80:248-52. (IF: 4,078)

Pucillo, C., R. Cepeda, and R.J. Hodes. 1993. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. J Exp Med. 178:1441-5. (IF: 11,240)

Altomonte, M., C. Pucillo, G. Damante, and M. Maio. 1993. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY. J Immunol. 151:5115-22. (IF: 4,985)

Pucillo, C., S. Salzano, S. Pepe, M. Vitale, S. Formisano, and G. Rossi. 1990. Regulation of the expression of the low-affinity IgE receptor (Fc epsilon RII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. Int Arch Allergy Appl Immunol. 93:330-7. (IF: 2,389)

Rivera, J., J.P. Kinet, J. Kim, C. Pucillo, and H. Metzger. 1988. Studies with a monoclonal antibody to the beta subunit of the receptor with high affinity for immunoglobulin E. Mol Immunol. 25:647-61. (IF:3,375)